Ameriprise’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.74B | Buy |
2,984,392
+97,128
| +3% | +$98.5M | 0.64% | 20 |
|
|
2025
Q4 | $3.1B | Sell |
2,887,264
-82,896
| -3% | -$79.3M | 0.7% | 16 |
|
|
2025
Q3 | $2.27B | Buy |
2,970,160
+52,090
| +2% | +$38.8M | 0.52% | 26 |
|
|
2025
Q2 | $2.27B | Sell |
2,918,070
-41,585
| -1% | -$32.3M | 0.56% | 21 |
|
|
2025
Q1 | $2.44B | Sell |
2,959,655
-28,516
| -1% | -$23.7M | 0.66% | 20 |
|
|
2024
Q4 | $2.31B | Buy |
2,988,171
+64,030
| +2% | +$53M | 0.59% | 23 |
|
|
2024
Q3 | $2.59B | Sell |
2,924,141
-103,760
| -3% | -$93.3M | 0.66% | 17 |
|
|
2024
Q2 | $2.74B | Buy |
3,027,901
+22,392
| +0.7% | +$17.9M | 0.74% | 14 |
|
|
2024
Q1 | $2.34B | Sell |
3,005,509
-145,947
| -5% | -$104M | 0.64% | 18 |
|
|
2023
Q4 | $1.84B | Sell |
3,151,456
-521,762
| -14% | -$305M | 0.55% | 29 |
|
|
2023
Q3 | $1.97B | Sell |
3,673,218
-432,630
| -11% | -$223M | 0.65% | 21 |
|
|
2023
Q2 | $1.93B | Sell |
4,105,848
-976,284
| -19% | -$409M | 0.6% | 23 |
|
|
2023
Q1 | $1.75B | Sell |
5,082,132
-288,589
| -5% | -$97.3M | 0.57% | 27 |
|
|
2022
Q4 | $1.96B | Sell |
5,370,721
-932,998
| -15% | -$331M | 0.67% | 21 |
|
|
2022
Q3 | $2.04B | Sell |
6,303,719
-979,498
| -13% | -$310M | 0.75% | 11 |
|
|
2022
Q2 | $2.36B | Sell |
7,283,217
-1,168,986
| -14% | -$351M | 0.82% | 10 |
|
|
2022
Q1 | $2.41B | Buy |
8,452,203
+476,150
| +6% | +$123M | 0.71% | 16 |
|
|
2021
Q4 | $2.19B | Sell |
7,976,053
-310,414
| -4% | -$78.7M | 0.61% | 24 |
|
|
2021
Q3 | $1.91B | Sell |
8,286,467
-447,123
| -5% | -$110M | 0.61% | 22 |
|
|
2021
Q2 | $2B | Buy |
8,733,590
+383,933
| +5% | +$77.1M | 0.62% | 23 |
|
|
2021
Q1 | $1.56B | Buy |
8,349,657
+908,748
| +12% | +$178M | 0.52% | 29 |
|
|
2020
Q4 | $1.26B | Buy |
7,440,909
+1,297,007
| +21% | +$194M | 0.45% | 39 |
|
|
2020
Q3 | $909M | Buy |
6,143,902
+24,901
| +0.4% | +$3.85M | 0.37% | 49 |
|
|
2020
Q2 | $1B | Buy |
6,119,001
+428,375
| +8% | +$65.8M | 0.43% | 42 |
|
|
2020
Q1 | $789M | Buy |
5,690,626
+2,352,012
| +70% | +$323M | 0.41% | 44 |
|
|
2019
Q4 | $439M | Buy |
3,338,614
+596,014
| +22% | +$69.1M | 0.18% | 121 |
|
|
2019
Q3 | $307M | Sell |
2,742,600
-1,703,835
| -38% | -$190M | 0.14% | 160 |
|
|
2019
Q2 | $493M | Sell |
4,446,435
-637,273
| -13% | -$75M | 0.22% | 94 |
|
|
2019
Q1 | $660M | Sell |
5,083,708
-569,969
| -10% | -$69.3M | 0.3% | 56 |
|
|
2018
Q4 | $654M | Sell |
5,653,677
-428,671
| -7% | -$47.9M | 0.33% | 58 |
|
|
2018
Q3 | $653M | Sell |
6,082,348
-428,028
| -7% | -$42.8M | 0.23% | 91 |
|
|
2018
Q2 | $556M | Buy |
6,510,376
+949,332
| +17% | +$78M | 0.25% | 84 |
|
|
2018
Q1 | $430M | Buy |
5,561,044
+2,508,641
| +82% | +$202M | 0.19% | 107 |
|
|
2017
Q4 | $258M | Buy |
3,052,403
+1,408,715
| +86% | +$120M | 0.12% | 185 |
|
|
2017
Q3 | $141M | Sell |
1,643,688
-7,552
| -0.5% | -$619K | 0.07% | 296 |
|
|
2017
Q2 | $136M | Sell |
1,651,240
-139,075
| -8% | -$11.3M | 0.07% | 294 |
|
|
2017
Q1 | $151M | Buy |
1,790,315
+115,410
| +7% | +$9.24M | 0.08% | 265 |
|
|
2016
Q4 | $123M | Sell |
1,674,905
-134,382
| -7% | -$10M | 0.07% | 295 |
|
|
2016
Q3 | $145M | Buy |
1,809,287
+973,900
| +117% | +$78M | 0.08% | 242 |
|
|
2016
Q2 | $65.8M | Buy |
835,387
+296,271
| +55% | +$22.3M | 0.04% | 408 |
|
|
2016
Q1 | $38.8M | Sell |
539,116
-2,475,457
| -82% | -$187M | 0.02% | 576 |
|
|
2015
Q4 | $254M | Buy |
3,014,573
+1,982,210
| +192% | +$164M | 0.15% | 143 |
|
|
2015
Q3 | $86.5M | Sell |
1,032,363
-156,597
| -13% | -$13.2M | 0.05% | 316 |
|
|
2015
Q2 | $99.3M | Sell |
1,188,960
-279,407
| -19% | -$21.3M | 0.06% | 319 |
|
|
2015
Q1 | $107M | Sell |
1,468,367
-895,936
| -38% | -$63.8M | 0.06% | 305 |
|
|
2014
Q4 | $163M | Sell |
2,364,303
-683,859
| -22% | -$46.2M | 0.1% | 215 |
|
|
2014
Q3 | $198M | Sell |
3,048,162
-1,954,463
| -39% | -$124M | 0.12% | 185 |
|
|
2014
Q2 | $311M | Sell |
5,002,625
-3,135,597
| -39% | -$187M | 0.18% | 129 |
|
|
2014
Q1 | $479M | Buy |
8,138,222
+1,226,221
| +18% | +$68.4M | 0.29% | 84 |
|
|
2013
Q4 | $353M | Buy |
6,912,001
+27,522
| +0.4% | +$1.38M | 0.21% | 113 |
|
|
2013
Q3 | $346M | Sell |
6,884,479
-1,132,934
| -14% | -$59.3M | 0.23% | 102 |
|
|
2013
Q2 | $394M | Buy |
+8,017,413
| New | +$436M | 0.27% | 73 |
|
Other funds holding LLY
VCM
VPM
Ameriprise's LLY Position: Q1 2026 in Review
Ameriprise increased its Eli Lilly (LLY) stake by 3.4% in Q1 2026, buying an estimated $98.5M and bringing the position to 2,984,392 shares worth $2.74B. The position accounts for 0.64% of the portfolio, ranked #20.
Ameriprise first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.1B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Ameriprise held 2,984,392 shares of Eli Lilly worth $2.74B as of Q1 2026.
- Ameriprise bought 97,128 Eli Lilly shares in Q1 2026, an estimated $98.5M.
- Eli Lilly made up 0.64% of Ameriprise's portfolio in Q1 2026, its #20 holding.
- Ameriprise first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Eli Lilly position peaked at $3.1B in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.